Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Lancet. Infectious Diseases|November 10, 2022
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational studyChiara Agrati, Andrea Cossarizza, Valentina Mazzotta, et al.Cell Death and Differentiation|June 10, 2020
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, et al.Frontiers in Immunology|March 21, 2022
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid ArthritisChiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, et al.Frontiers in Immunology|October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis PatientsAndrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 3, 2022
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal studyChiara Farroni, Alessandra Aiello, Andrea Picchianti-Diamanti, et al.Eclinicalmedicine|January 31, 2024
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort studyValentina Mazzotta, Alessandro Cozzi Lepri, Giulia Matusali, et al.Vaccines|January 24, 2025
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous RouteValentina Mazzotta, Pierluca Piselli, Alessandro Cozzi Lepri, et al.NPJ Vaccines|September 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial resultsChiara Agrati, Concetta Castilletti, Simone Battella, et al.Pageof 4